Helicore Biopharma - Crunchbase Company Profile & Funding

Q: Who invested in Helicore Biopharma?

Helicore Biopharma has 4 investors including OrbiMed And Longitude Capital.

Q: How much funding has Helicore Biopharma raised to date?

Helicore Biopharma has raised obfuscated.

Overview

Helicore Biopharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Helicore Biopharma

CB Rank

23963

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

Founded

obfuscation

Private

Series A

San Mateo, California, United States

1-10

www.helicore.com/

Biopharma

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Key People

Jing Liang: Co-Founder & Board Director
Past Role: Attenua, Founder
Gerrit Klaerner: Chief Executive Officer & President
Past Role: Relypsa, President & Founder ,Member of Board of Directors

Details

Legal Name

Helicore Biopharma, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Jing Liang

About the Company

Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders.

Phone Number

+1 650-332-2600

Contact Email

info@helicore.com

Predictions & Insights

Growth Insight

See this Growth Insight

Helicore Biopharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

HCR-188

A monoclonal antibody that binds circulating GIP ligand to antagonize GIP signaling for obesity treatment.

GIP Antibody Conjugates (including GLP-1 combinations)

A portfolio of antibody conjugates targeting GIP and GLP-1 pathways to address specific obesity subpopulations.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A
obfuscated obfuscation	Series A - Helicore Biopharma	4	obfuscated obfuscation	OrbiMed, Versant Ventures	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
OrbiMed	Yes	Series A - Helicore Biopharma	Rishi Gupta
OrbiMed	Yes	Series A - Helicore Biopharma	Rishi Gupta
OrbiMed	Yes	Series A - Helicore Biopharma	Rishi Gupta
OrbiMed	Yes	Series A - Helicore Biopharma	Rishi Gupta
OrbiMed	Yes	Series A - Helicore Biopharma	Rishi Gupta